Brightgene Bio-Medical Technology Co., Ltd.

China


Create a watch for Brightgene Bio-Medical Technology Co., Ltd.
Total IP 65
Total IP Rank # 21,213
IP Activity Score 2.4/5.0    33
IP Activity Rank # 23,000
Stock Symbol 688166 (sse)
Market Cap. 10.041B  (CNY)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

14 1
11 0
38 1
0
 
Last Patent 2025 - Pharmaceutical composition compr...
First Patent 2006 - Nucleotide analogue prodrug and ...
Last Trademark 2019 - BRIGHTGENE
First Trademark 2019 - BRIGHTGENE

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Pharmaceutical composition comprising glp-1 and gip dual-receptor agonist and use thereof. A phar...
2024 Invention Preparation method for dual gip and glp-1 receptor agonist. A preparation method for a dual GIP a...
2023 Invention Pharmaceutical composition comprising lurbinectedin, preparation method therefor, and use thereof...
Invention Gip and glp-1 dual receptor agonist, pharmaceutical composition, and use. A GIP and GLP-1 dual re...
Invention Dual glp-1 and gip receptor agonist pharmaceutical composition and use thereof. The present inven...
Invention Antibody-drug conjugate, and pharmaceutical composition and use thereof. Disclosed are an antibod...
Invention Linker for preparing antibody-drug conjugate, compound, and use. The present disclosure relates t...
2022 Invention Gip and glp-1 dual receptor agonist, pharmaceutical composition, and use. A GIP and GLP-1 dual r...
Invention Anti-her2 antibody-immune agonist conjugate and applications thereof. The disclosure relates to ...
Invention Anti-her2 antibody-immune agonist conjugate and applications thereof. The disclosure relates to a...
2020 Invention Antibody conjugate intermediate and preparation method therefor. Provided is an antibody conjugat...
Invention Method for use in preparing obeticholic acid. Provided in the present invention is a method for u...
Invention Method for preparing laninamivir. The present invention relates to a method for preparing laninam...
Invention Method for preparing laninamivir octanoate intermediate by means of one-pot synthesis. 11211 is b...
Invention Eribulin and preparation method for intermediate thereof. Provided is eribulin and a preparation ...
Invention Cd44 targeted multi-arm conjugate. Disclosed is a class of multi-branched drug conjugates capabl...
Invention Cd44 targeted multi-arm conjugate. Disclosed is a class of multi-branched drug conjugates capable...
Invention Benzopyridone heterocyclic compound and use thereof. A compound represented by formula I, or a p...
Invention Benzopyridone heterocyclic compound and use thereof. A compound represented by formula I, or a ph...
2019 Invention Phosphoramidate compound and preparation method and crystal thereof. The present disclosure invol...
Invention Compound having dinucleotide structure. Provided is a novel compound having a dinucleotide struct...
Invention Dinucleotide precursor for drug and preparation method therefor. Provided are a dinucleotide prec...
G/S Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascul...
G/S Injectable solutions for medical purposes; prepared Chinese medicine; chemico-pharmaceutical pre...
Invention Preparation method for ecteinascidin compound and intermediate thereof. The present invention pro...
2018 Invention Integrin receptor-targeted anti-cancer conjugate. Disclosed is a heptane sulfonate of a targeted ...
Invention Multi-arm targeting conjugate. Disclosed is an anti-cancer targeting conjugate modified by a mult...
Invention Ovarian cancer specifically targeted biodegradable amphiphilic polymer, polymer vesicle prepared ...
Invention Composition containing l-carnitine and β-hydroxybutyrate compound. Provided are a composition con...
Invention Composition containing l-carnitine-β-hydroxybutyrate and preparation method thereof. Provided is ...
Invention Multi-arm targeting anti-cancer conjugate. A multi-branched drug conjugate of formula (I) or a ph...
Invention Multi-arm targeted anti-cancer conjugate. A multi-branched drug conjugate of formula (I) or a pha...
2017 Invention Polymorph of nucleoside phosphoramidate prodrug and preparation method therefor. Provided are a c...
Invention Multi-arm polymeric targeting anti-cancer conjugate. Disclosed is a multi-arm targeting drug conj...
Invention Multi-arm polymeric targeting anti-cancer conjugate. Disclosed is a multi-arm targeting drug coup...
2016 Invention Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biod...
Invention Biodegradable amphiphilic polymer, polymer vesicle prepared therefrom and use in preparing target...
Invention Exenatide modifier and use thereof. Disclosed are an exenatide modifier for connecting the exenat...
Invention Composition enriched in single isomer of nuc-1031 and preparation method and use thereof. p-1. Al...
Invention Preparation method of nucleoside phosphoramidate prodrugs and intermediates thereof. Provided in...
Invention Phosphoramidate compound and preparation method and crystal thereof. The present invention involv...
Invention Composition rich in single isomer nuc-1031 and preparation method and use thereof. Provided is a ...
Invention Preparation method of nucleoside phosphoramidate prodrugs and intermediates thereof. Provided in ...
Invention Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof. Disclosed ...
2015 Invention Himbacine analogue and method for preparing intermediate thereof. The present invention provides ...
Invention Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and prepar...